Orphan drugs and metabolic disorders;Medicamentos huérfanos y enfermedades metabólicas

Revista de Neurologia

Volumn 33, Issue 3, 2001, Pages 220-225

  Martinez Pardo M ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Betaine; Metabolic disease; N carbamyl glutamate; Orphan drugs; Tetrahydrobiopterin

Indexed keywords

BETAINE; GLUTAMATE ACETYLTRANSFERASE; GLUTAMIC ACID DERIVATIVE; N CARBAMYLGLUTAMATE; ORPHAN DRUG; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG;

BRAIN EDEMA; CONFERENCE PAPER; ENZYME DEFICIENCY; HYPERAMMONEMIA; HYPERHOMOCYSTEINEMIA; INCIDENCE; METABOLIC DISORDER; THROMBOEMBOLISM;

EID: 17344395558     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3303.2001158     Document Type: Conference Paper

References (13)

1. Orphan drugs and orphan diseases. Round table proceedings
2. Protocolo de diagnóstico, tratamiento y seguimiento de las hiperfenilalaninemias
3. A typical cases of Phenylketonuria
4. 4)
5. Tetrahydrobiopterin deficiency: From phenotype to genotype
6. Monitoring treatment in tetrahydrobiopterin deficiency by serum prolactin
7. N-acetylglutamate synthetase deficiency: A disorder of ammonia detoxification
8. Alternative pathway therapy for urea cycle disorders. Advances in inherited urea cycle disorders. Proceedings of a Symposium, Vienna May 1997
9. N-acetylglutamate synthetase deficiency a second patient
10. Partial N-acetylglutamate synthetase deficiency: Diagnosis and response to treatment with N-carbamyl-glutamate
11. Urea cycle enzymes
12. Deficiencia de N-acetilglutamato sintetasa (NAGS) en un adolescente con psicosis e hiperamonemia